Dyne reported improvements in hand movement, function, strength, and patient-reported symptoms, with no related serious side effects. The results are encouraging, but most participants did not receive the planned dose for the full year, and results from a larger group are still pending.
These findings strengthen the case that Dyne’s drug may help people with DM1. Improvements appeared in hand movement, walking, standing, strength, and patient-reported symptoms. The company also reported no serious side effects tied to treatment.
Follow Dyne Therapeutics, Inc. (DYN) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for DYN